Refine Results
- 必威体育赛事投注
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
To be enabled for e-commerce, you must first register.必威体育登录手机Agilent will then confirm your registration and inform you when your enablement is complete and you can begin transacting.
E-commerce is currently not available in your country.必威体育登录手机For select consumables and supplies you may now use Saved Cart link under your Account to build lists and send to your Agilent Representative.Simply login or register and you may begin.
A high-resolution accurate mass LC/Q-TOF acquisition and data analysis workflow for ~150 new synthetic fentanyl analogues and 4-ANPP is described.
- Publication Part Number: 5994-1742EN
- Created: 12 Mar 2020
- 3 MB
Investigates replacing immunoassay-based drug screening and creatinine quantitation by a rapid LC/TOF MS screen with increased specificity and accuracy.
- Publication Part Number: 5994-0189EN
- Created: 21 Aug 2018
- 663 KB
必威体育登录手机Quantitative determination of drugs of abuse in human whole blood by LC/MS/MS using Agilent Captiva EMR—Lipid cleanup.
- Publication Part Number: 5991-9251EN
- Created: 19 Apr 2018
- 1 MB
Use of Resolve allows the examination a maximum range of packages or containers for indications of hazardous materials before disturbing, opening, or taking a sample.
- Publication Part Number: 5991-8877EN
- Created: 23 Feb 2018
- 2 MB